Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities
The immunosuppressive tumor microenvironment (TIME) remains a major barrier to cancer immunotherapy, creating an urgent need for agents that can simultaneously remodel the TIME and potentiate immune checkpoint blockade. In this review, we propose the c…